| Net income | |
| Depreciation and amortization | 459M |
| Share-based compensation expense | 79M |
| Other non-cash items | 5M |
| Receivables | -657M |
| Inventories | 162M |
| Drafts and accounts payable | 2.17B |
| Deferred revenue | -254M |
| Other | -390M |
| Net cash provided by operating activities | 2.93B |
| Property acquisitions | -151M |
| Capitalized software expenditures | |
| Acquisition of business, less cash and cash equivalents acquired | -2.04B |
| Other | 98M |
| Net cash used in investing activities | -1.35B |
| Repayments of debt | |
| Common stock repurchases, including shares surrendered for tax withholding | -58M |
| Common stock transactions - other | |
| Dividends paid | -129M |
| Other | 11M |
| Net cash used in financing activities | -114M |
| Effect of exchange rate changes on cash and cash equivalents | -52M |
| Net decrease in cash and cash equivalents | 1.42B |
| Cash and cash equivalents at beginning of period | 4.05B |
| Cash and cash equivalents at end of period | 5.46B |